These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 473381)

  • 21. [Procedure in case of suspected mycobacterial infection of lymph nodes of the neck. 2. Therapy].
    Göpel B; Götte K
    Laryngorhinootologie; 2005 Aug; 84(8):610-9; quiz 621-2. PubMed ID: 16080064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Six months versus nine months chemotherapy for tuberculosis of lymph nodes: final results.
    Campbell IA; Ormerod LP; Friend JA; Jenkins PA; Prescott RJ
    Respir Med; 1993 Nov; 87(8):621-3. PubMed ID: 8290746
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 24. Prospective randomized study of thrice weekly six-month and nine-month chemotherapy for cervical tuberculous lymphadenopathy.
    Yuen AP; Wong SH; Tam CM; Chan SL; Wei WI; Lau SK
    Otolaryngol Head Neck Surg; 1997 Feb; 116(2):189-92. PubMed ID: 9051062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A controlled trial of 6 months' chemotherapy in pulmonary tuberculosis. Final report: results during the 36 months after the end of chemotherapy and beyond. British Thoracic Society.
    Br J Dis Chest; 1984 Oct; 78(4):330-6. PubMed ID: 6386028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of tuberculous masses in the neck.
    Deitel M; Saldanha CF; Borowy ZJ; Ronald AC; Krajden S
    Can J Surg; 1984 Jan; 27(1):90-3. PubMed ID: 6467109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effectiveness of INH-rifampicin treatment of lymph node tuberculosis].
    Weinecke A
    Z Erkr Atmungsorgane; 1989; 173(1):63-7. PubMed ID: 2800617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Quantitative evaluation of the dynamics of tubercular mediastinal adenopathy treated with rifampicin and ethambutol].
    Tonceanu S; Bazacliu E; Carp G; Varadi P; Ritter S; Simon F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(3):143-50. PubMed ID: 201006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Enormous subclavicular, mediastinal and retroperitoneal tuberculous lymphadenopathy in a young adult patient (author's transl)].
    Mannes P; Bosly A; Delporte F
    Acta Tuberc Pneumol Belg; 1971; 62(5):467-72. PubMed ID: 5163924
    [No Abstract]   [Full Text] [Related]  

  • 31. A retrospective comparison of two drug regimens RHE2/RH10 and RHZ2/RH10 in the treatment of tuberculous mediastinal lymphadenopathy.
    Ormerod LP
    Br J Dis Chest; 1988 Jul; 82(3):274-81. PubMed ID: 3248208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trial of two intermittent short-course regimens (78 doses) in the initial treatment of pulmonary tuberculosis.
    Tubercle; 1977 Mar; 58(1):1-8. PubMed ID: 325837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drug-resistance of Mycobacterium tuberculosis in Patras, Greece.
    Trakada G; Tsiamita M; Spiropoulos K
    Monaldi Arch Chest Dis; 2004; 61(1):65-70. PubMed ID: 15366340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A triple regimen of streptomycin, isoniazid and ethambutol or rifampicin, isoniazid and ethambutol in untreated cases of pulmonary tuberculosis. 3.
    Oka S; Sasaki M; Kobayashi T; Matsuda T
    Sci Rep Res Inst Tohoku Univ Med; 1972 Sep; 19(2):84-8. PubMed ID: 4649627
    [No Abstract]   [Full Text] [Related]  

  • 35. [Optimization of chemotherapy regimens in children with primary pulmonary tuberculosis].
    Ovchinnikova IuE; Starshinova AA; Dovgaliuk IF
    Probl Tuberk Bolezn Legk; 2009; (1):36-40. PubMed ID: 19256011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six-month combination chemotherapy for cervical tuberculous lymphadenitis.
    Cheung WL; Siu KF; Ng A
    J R Coll Surg Edinb; 1990 Oct; 35(5):293-5. PubMed ID: 2283606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Present status of chemotherapy for tuberculosis.
    Grosset JH
    Rev Infect Dis; 1989; 11 Suppl 2():S347-52. PubMed ID: 2652251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current aspects of the therapy of lymph node tuberculosis].
    Pescetti G; Porrino F; Rodicchi A
    Minerva Med; 1973; 64(43):2259-63. PubMed ID: 4727515
    [No Abstract]   [Full Text] [Related]  

  • 39. Six months' chemotherapy for lymph node tuberculosis.
    McCarthy OR; Rudd RM
    Respir Med; 1989 Sep; 83(5):425-7. PubMed ID: 2616826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Which treatment for primary tuberculosis?].
    Gallet S; Bellon G
    Pediatrie; 1989; 44(9):699-704. PubMed ID: 2695890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.